{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T02:44:46Z","timestamp":1790995486818,"version":"4.1.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2011,1,14]],"date-time":"2011-01-14T00:00:00Z","timestamp":1294963200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s12016-010-8245-8","type":"journal-article","created":{"date-parts":[[2011,1,13]],"date-time":"2011-01-13T03:45:37Z","timestamp":1294890337000},"page":"190-197","source":"Crossref","is-referenced-by-count":89,"title":["Cutting Edge: The Etiology of Autoimmune Thyroid Diseases"],"prefix":"10.1007","volume":"41","author":[{"given":"Deirdre Cocks","family":"Eschler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alia","family":"Hasham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaron","family":"Tomer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,1,14]]},"reference":[{"key":"8245_CR1","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1210\/er.2008-0015","volume":"29","author":"A Huber","year":"2008","unstructured":"Huber A, Menconi F, Corathers S, Jacobson EM, Tomer Y (2008) Joint genetic susceptibility to type 1 diabetes and autoimmune thyroiditis: from epidemiology to mechanisms. Endocr Rev 29:697\u2013725","journal-title":"Endocr Rev"},{"key":"8245_CR2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/clin.1997.4412","volume":"84","author":"DL Jacobson","year":"223","unstructured":"Jacobson DL, Gange SJ, Rose NR, Graham NM (223) Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 84:223\u2013243","journal-title":"Clin Immunol Immunopathol"},{"key":"8245_CR3","first-page":"721","volume-title":"Werner and Ingbar's The thyroid","author":"AP Weetman","year":"2000","unstructured":"Weetman AP (2000) Chronic autoimmune thyroiditis. In: Braverman LE, Utiger RD (eds) Werner and Ingbar's The thyroid. Lippincott Williams and Wilkins, Philadelphia, pp 721\u2013732"},{"key":"8245_CR4","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/978-1-60327-285-8_44","volume-title":"Diagnostic criteria in autoimmune diseases","author":"F Menconi","year":"2008","unstructured":"Menconi F, Oppenheim YL, Tomer Y (2008) Graves' disease. In: Shoenfeld Y, Cervera R, Gershwin ME (eds) Diagnostic criteria in autoimmune diseases. Humana Press, Totowa, NJ, pp 231\u2013235"},{"key":"8245_CR5","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1034\/j.1399-0039.2002.590202.x","volume":"59","author":"JA Gebe","year":"2002","unstructured":"Gebe JA, Swanson E, Kwok WW (2002) HLA class II peptide-binding and autoimmunity. Tissue Antigens 59:78\u201387","journal-title":"Tissue Antigens"},{"key":"8245_CR6","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1089\/thy.2010.1644","volume":"20","author":"Y Tomer","year":"2010","unstructured":"Tomer Y (2010) Genetic susceptibility to autoimmune thyroid disease: past, present, and future. Thyroid 20:715\u2013725","journal-title":"Thyroid"},{"key":"8245_CR7","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.1210\/jc.2004-2236","volume":"90","author":"B Golden","year":"2005","unstructured":"Golden B, Levin L, Ban Y, Concepcion E, Greenberg DA, Tomer Y (2005) Genetic analysis of families with autoimmune diabetes and thyroiditis: evidence for common and unique genes. J Clin Endocrinol Metab 90:4904\u20134911","journal-title":"J Clin Endocrinol Metab"},{"key":"8245_CR8","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jaut.2007.11.010","volume":"30","author":"EM Jacobson","year":"2008","unstructured":"Jacobson EM, Huber A, Tomer Y (2008) The HLA gene complex in thyroid autoimmunity: from epidemiology to etiology. J Autoimmun 30:58\u201362","journal-title":"J Autoimmun"},{"key":"8245_CR9","doi-asserted-by":"crossref","first-page":"14034","DOI":"10.1073\/pnas.0806584105","volume":"105","author":"F Menconi","year":"2008","unstructured":"Menconi F, Monti MC, Greenberg DA et al (2008) Molecular amino acid signatures in the MHC class II peptide-binding pocket predispose to autoimmune thyroiditis in humans and in mice. Proc Natl Acad Sci USA 105:14034\u201314039","journal-title":"Proc Natl Acad Sci USA"},{"key":"8245_CR10","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1089\/10507250150500630","volume":"11","author":"LM Maciel","year":"2001","unstructured":"Maciel LM, Rodrigues SS, Dibbern RS, Navarro PA, Donadi EA (2001) Association of the HLA-DRB1*0301 and HLA-DQA1*0501 alleles with Graves' disease in a population representing the gene contribution from several ethnic backgrounds. Thyroid 11:31\u201335","journal-title":"Thyroid"},{"key":"8245_CR11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/sj.gene.6364059","volume":"5","author":"Y Ban","year":"2004","unstructured":"Ban Y, Davies TF, Greenberg DA et al (2004) Arginine at position 74 of the HLA-DR beta1 chain is associated with Graves' disease. Genes Immun 5:203\u2013208","journal-title":"Genes Immun"},{"key":"8245_CR12","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1089\/thy.2006.16.351","volume":"16","author":"SE Hodge","year":"2006","unstructured":"Hodge SE, Ban Y, Strug LJ et al (2006) Possible interaction between HLA-DRbeta1 and thyroglobulin variants in Graves' disease. Thyroid 16:351\u2013355","journal-title":"Thyroid"},{"key":"8245_CR13","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jaut.2007.02.006","volume":"28","author":"EM Jacobson","year":"2007","unstructured":"Jacobson EM, Tomer Y (2007) The CD40, CTLA-4, thyroglobulin, TSH receptor, and PTPN22 gene quintet and its contribution to thyroid autoimmunity: back to the future. J Autoimmun 28:85\u201398","journal-title":"J Autoimmun"},{"key":"8245_CR14","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1089\/105072502321085234","volume":"12","author":"Y Tomer","year":"2002","unstructured":"Tomer Y, Concepcion E, Greenberg DA (2002) A C\/T single-nucleotide polymorphism in the region of the CD40 gene is associated with Graves' disease. Thyroid 12:1129\u20131135","journal-title":"Thyroid"},{"key":"8245_CR15","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1210\/en.2004-1617","volume":"146","author":"EM Jacobson","year":"2005","unstructured":"Jacobson EM, Concepcion E, Oashi T, Tomer Y (2005) A Graves' disease-associated Kozak sequence single-nucleotide polymorphism enhances the efficiency of CD40 gene translation: a case for translational pathophysiology. Endocrinology 146:2684\u20132691","journal-title":"Endocrinology"},{"key":"8245_CR16","doi-asserted-by":"crossref","first-page":"5784","DOI":"10.4049\/jimmunol.162.10.5784","volume":"162","author":"R Khattri","year":"1999","unstructured":"Khattri R, Auger JA, Griffin MD, Sharpe AH, Bluestone JA (1999) Lymphoproliferative disorder in CTLA-4 knockout mice is characterized by CD28-regulated activation of Th2 responses. J Immunol 162:5784\u20135791","journal-title":"J Immunol"},{"key":"8245_CR17","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nature01621","volume":"423","author":"H Ueda","year":"2003","unstructured":"Ueda H, Howson JM, Esposito L et al (2003) Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease. Nature 423:506\u2013511","journal-title":"Nature"},{"key":"8245_CR18","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1080\/08916930701510848","volume":"40","author":"SA Chung","year":"2007","unstructured":"Chung SA, Criswell LA (2007) PTPN22: its role in SLE and autoimmunity. Autoimmunity 40:582\u2013590","journal-title":"Autoimmunity"},{"key":"8245_CR19","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1086\/518257","volume":"80","author":"Y Yang","year":"2007","unstructured":"Yang Y, Chung EK, Wu YL et al (2007) Gene copy-number variation and associated polymorphisms of complement component C4 in human systemic lupus erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against SLE susceptibility in European Americans. Am J Hum Genet 80:1037\u20131054","journal-title":"Am J Hum Genet"},{"key":"8245_CR20","unstructured":"Huber AK, Concepcion ES, Gandhi A, et al. (2010), Analysis of Immune Regulatory Genes' Copy Number Variants in Graves' Disease. Thyroid. Nov 8"},{"key":"8245_CR21","doi-asserted-by":"crossref","first-page":"15119","DOI":"10.1073\/pnas.2434175100","volume":"100","author":"Y Ban","year":"2003","unstructured":"Ban Y, Greenberg DA, Concepcion E, Skrabanek L, Villanueva R, Tomer Y (2003) Amino acid substitutions in the thyroglobulin gene are associated with susceptibility to human and murine autoimmune thyroid disease. Proc Natl Acad Sci U S A 100:15119\u201315124","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8245_CR22","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1086\/378588","volume":"73","author":"Y Tomer","year":"2003","unstructured":"Tomer Y, Ban Y, Concepcion E et al (2003) Common and unique susceptibility loci in Graves and Hashimoto diseases: results of whole-genome screening in a data set of 102 multiplex families. Am J Hum Genet 73:736\u2013747","journal-title":"Am J Hum Genet"},{"key":"8245_CR23","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1089\/thy.2010.1636","volume":"20","author":"GA Brent","year":"2010","unstructured":"Brent GA (2010) Environmental exposures and autoimmune thyroid disease. Thyroid 20:755\u2013761","journal-title":"Thyroid"},{"key":"8245_CR24","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1089\/thy.2006.0299","volume":"17","author":"L Papanastasiou","year":"2007","unstructured":"Papanastasiou L, Vatalas L, Koutras DA, Mastorakos G (2007) Thyroid autoimmunity in the current iodine environment. Thyroid 17:729\u2013739","journal-title":"Thyroid"},{"key":"8245_CR25","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1056\/NEJMoa054022","volume":"354","author":"W Teng","year":"2006","unstructured":"Teng W, Shan Z, Teng X et al (2006) Effect of iodine intake on thyroid diseases in China. N Engl J Med 354:2783\u20132793","journal-title":"N Engl J Med"},{"key":"8245_CR26","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1530\/eje.0.1400505","volume":"140","author":"AG Doufas","year":"1999","unstructured":"Doufas AG, Mastorakos G, Chatziioannou S et al (1999) The predominant form of non-toxic goiter in Greece is now autoimmune thyroiditis. Eur J Endocrinol 140:505\u2013511","journal-title":"Eur J Endocrinol"},{"key":"8245_CR27","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1530\/eje.0.1390290","volume":"139","author":"GJ Kahaly","year":"1998","unstructured":"Kahaly GJ, Dienes HP, Beyer J, Hommel G (1998) Iodide induced thyroid autoimmunity in patients with endemic goiter: a randomized, double blind, placebo controlled trial. Eur J Endocrinol 139:290\u2013297","journal-title":"Eur J Endocrinol"},{"key":"8245_CR28","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jaut.2009.09.001","volume":"33","author":"CL Burek","year":"2009","unstructured":"Burek CL, Talor MV (2009) Environmental triggers of autoimmune thyroiditis. J Autoimmun 33:183\u2013189","journal-title":"J Autoimmun"},{"key":"8245_CR29","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1055\/s-0029-1215568","volume":"41","author":"ML Tanda","year":"2009","unstructured":"Tanda ML, Piatanida E, Lai A et al (2009) Thyroid autoimmunity and environment. Horm Metab Res 41:436\u2013442","journal-title":"Horm Metab Res"},{"key":"8245_CR30","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1210\/jc.2010-0180","volume":"95","author":"F Bogazzi","year":"2010","unstructured":"Bogazzi F, Bartalena L, Martino E (2010) Approach to the patient with amiodarone-induced thyrotoxicosis. J Clin Endocrinol Metab 95:2529\u20132535","journal-title":"J Clin Endocrinol Metab"},{"key":"8245_CR31","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1089\/105072501300176471","volume":"11","author":"F Bogazzi","year":"2001","unstructured":"Bogazzi F, Bartalena L, Gasperi M, Braverman LE, Martino E (2001) The various effects of amiodarone on thyroid function. Thyroid 11:511\u2013519","journal-title":"Thyroid"},{"key":"8245_CR32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1530\/eje.0.1370089","volume":"137","author":"V Pitsiavas","year":"1997","unstructured":"Pitsiavas V, Smerdely P, Li M, Boyages SC (1997) Amiodarone induces a different pattern of ultrastructural change in the thyroid to iodine excess alone in both the BB\/W rat and the Wistar rat. Eur J Endocrinol 137:89\u201398","journal-title":"Eur J Endocrinol"},{"key":"8245_CR33","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10741-008-9131-9","volume":"15","author":"WM Wiersinga","year":"2010","unstructured":"Wiersinga WM (2010) The role of thyroid hormone nuclear receptors in the heart: evidence from pharmacological approaches. Heart Fail Rev 15:121\u2013124","journal-title":"Heart Fail Rev"},{"key":"8245_CR34","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ejphar.2007.09.039","volume":"578","author":"RQ Shi","year":"2008","unstructured":"Shi RQ, Lee JK, Hayashi Y et al (2008) Long term amiodarone treatment causes cardioselective hypothyroid-like alteration in gene expression profile. Eur J Pharmacol 578:270\u2013278","journal-title":"Eur J Pharmacol"},{"key":"8245_CR35","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/01.md.0000159082.45703.90","volume":"84","author":"F Chen","year":"2005","unstructured":"Chen F, Day SL, Metcalfe RA et al (2005) Characteristics of autoimmune thyroid disease occurring as a late complication of immune reconstitution in patients with advances human immunodeficiency virus (HIV) disease. Medicine 84:98\u2013106","journal-title":"Medicine"},{"key":"8245_CR36","doi-asserted-by":"crossref","first-page":"4254","DOI":"10.1210\/jc.85.11.4254","volume":"85","author":"V Jubault","year":"2000","unstructured":"Jubault V, Penfornis A, Schillo F et al (2000) Sequential occurrence of thyroid autoantibodies and Graves\u2019 disease after immune restoration in severely immunocompromised human immunodeficiency virus-1 infected patients. J Clin Endocrinol Metab 85:4254\u20134257","journal-title":"J Clin Endocrinol Metab"},{"key":"8245_CR37","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1365-2265.2006.02472.x","volume":"64","author":"G Madeddu","year":"2006","unstructured":"Madeddu G, Spanu A, Chessa F et al (2006) Thyroid function in human immunodeficiency virus patients treated with highly active antiretroviral therapy (HAART): a longitudinal study. Clin Endocrinol 64:375\u2013383","journal-title":"Clin Endocrinol"},{"key":"8245_CR38","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.beem.2009.07.004","volume":"23","author":"Y Tomer","year":"2009","unstructured":"Tomer Y, Menconi F (2009) Interferon induced thyroiditis. Best Pract Res Clin Endocrinol Metab 23:703\u2013712","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"8245_CR39","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.21146","volume":"43","author":"JC Mandac","year":"2006","unstructured":"Mandac JC, Chaudhry S, Sherman KE, Tomer Y (2006) The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification. Hepatology 43:661\u2013672","journal-title":"Hepatology"},{"key":"8245_CR40","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.amjmed.2004.01.023","volume":"117","author":"A Antonelli","year":"2004","unstructured":"Antonelli A, Ferri C, Pampana A et al (2004) Thyroid disorders in chronic hepatitis C. Am J Med 117:10\u201313","journal-title":"Am J Med"},{"key":"8245_CR41","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jaut.2009.02.007","volume":"32","author":"Y Tomer","year":"2009","unstructured":"Tomer Y, Huber A (2009) The etiology of autoimmune thyroid disease: a story of genes and environment. J Autoimmun 32:231\u2013239","journal-title":"J Autoimmun"},{"key":"8245_CR42","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1743-422X-6-5","volume":"6","author":"R Desailloud","year":"2009","unstructured":"Desailloud R, Hober D (2009) Viruses and thyroiditis: an update. Virol J 6:5","journal-title":"Virol J"},{"key":"8245_CR43","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1089\/thy.2006.16.225","volume":"16","author":"S Benvenga","year":"2006","unstructured":"Benvenga S, Santarpia L, Trimarchi F, Guarneri F (2006) Human thyroid autoantigens and proteins of Yersinia and Borrelia share amino acid sequence homology that includes binding motifs to HLA-DR molecules and T-cell receptor. Thyroid 16:225\u2013236","journal-title":"Thyroid"},{"key":"8245_CR44","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1089\/thy.2005.15.1273","volume":"15","author":"H Volzke","year":"2005","unstructured":"Volzke H, Werner A, Guertler L, Robinson D, Wallaschofski H, John U (2005) Putative association between anti-Borrelia IgG and autoimmune thyroid disease? Thyroid 15:1273\u20131277","journal-title":"Thyroid"},{"key":"8245_CR45","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1530\/eje.0.1500605","volume":"150","author":"MF Prummel","year":"2004","unstructured":"Prummel MF, Strieder T, Wiersinga WM (2004) The environment and autoimmune thyroid diseases. Eur J Endocrinol 150:605\u2013618","journal-title":"Eur J Endocrinol"},{"key":"8245_CR46","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.amjmed.2004.04.004","volume":"117","author":"Y Tomer","year":"2004","unstructured":"Tomer Y, Villanueva R (2004) Hepatitis C and thyroid autoimmunity: is there a link? Am J Med 117:60\u201361","journal-title":"Am J Med"},{"key":"8245_CR47","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1006\/jaut.1999.0360","volume":"14","author":"MA Ganne-Carrie","year":"2000","unstructured":"Ganne-Carrie MA, Coderc E et al (2000) Latent autoimmune thyroiditis in untreated patients with HCV chronic hepatitis: a case control study. J Autoimmun 14:189\u2013193","journal-title":"J Autoimmun"},{"key":"8245_CR48","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1590\/S1413-86702008000200009","volume":"12","author":"LJ Andrade","year":"2008","unstructured":"Andrade LJ, Atta AM, D'Almeida Junior A, Paran\u00e1 R (2008) Thyroid dysfunction in hepatitis C individuals treated with interferon-alpha and ribavirin\u2014a review. Braz J Infect Dis 12:144\u2013148","journal-title":"Braz J Infect Dis"},{"key":"8245_CR49","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1530\/eje.0.1420431","volume":"142","author":"MC Hsieh","year":"2000","unstructured":"Hsieh MC, Yu ML, Chuang WL et al (2000) Virologic factors related to interferon alpha induced thyroid dysfunction in patients with chronic hepatitis C. Eur J Endocrinol 142:431\u2013437","journal-title":"Eur J Endocrinol"},{"key":"8245_CR50","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/jmv.21269","volume":"80","author":"J Bartolome","year":"2008","unstructured":"Bartolome J (2008) Detection of hepatitis C virus in thyroid tissue from patients with chronic HCV infection. J Med Virol 80:1588\u20131594","journal-title":"J Med Virol"},{"key":"8245_CR51","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jaut.2008.08.001","volume":"31","author":"N Akeno","year":"2008","unstructured":"Akeno N, Blackard JT, Tomer Y (2008) HCV E2 protein binds directly to thyroid cells and induces IL-8 production: a new mechanism for HCV induced thyroid autoimmunity. J Autoimmun 31:339\u2013344","journal-title":"J Autoimmun"},{"key":"8245_CR52","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/MED.0b013e3283305af7","volume":"16","author":"M Boas","year":"2009","unstructured":"Boas M, Main KM, Feldt-Rasmussen U (2009) Environmental chemicals and thyroid function: an update. Curr Opin Endocrinol Diab Obes 16:385\u2013391","journal-title":"Curr Opin Endocrinol Diab Obes"},{"key":"8245_CR53","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1056\/NEJM198001033020105","volume":"302","author":"AK Bahn","year":"1980","unstructured":"Bahn AK, Mills JL, Snyder PJ et al (1980) Hypothyroidism in workers exposed to polybrominated biphenyls. N Engl J Med 302:31\u201333","journal-title":"N Engl J Med"},{"key":"8245_CR54","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.1210\/jc.2002-020209","volume":"87","author":"K Moriyama","year":"2002","unstructured":"Moriyama K, Tagami T, Akamizu T et al (2002) Thyroid hormone action is disrupted by bisphenol A as an antagonist. J Clin Endocrinol Metab 87:5185\u20135190","journal-title":"J Clin Endocrinol Metab"},{"key":"8245_CR55","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/BOR.0b013e3283389641","volume":"22","author":"A Jungel","year":"2010","unstructured":"Jungel A, Ospelt C, Gay S (2010) What can we learn from epigenetics in the year 2009? Curr Opin Rheumatol 22:284\u2013292","journal-title":"Curr Opin Rheumatol"},{"key":"8245_CR56","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/j.cell.2007.05.009","volume":"129","author":"A Barski","year":"2007","unstructured":"Barski A, Cuddapah S, Cui K et al (2007) High-resolution profiling of histone methylations in the human genome. Cell 129:823\u2013837","journal-title":"Cell"},{"key":"8245_CR57","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1755-8794-3-33","volume":"3","author":"CG Bell","year":"2010","unstructured":"Bell CG, Teschendorff AE, Rakyan VK, Maxwell AP, Beck S, Savage DA (2010) Genome-wide DNA methylation analysis for diabetic nephropathy in type 1 diabetes mellitus. BMC Med Genomics 3:33","journal-title":"BMC Med Genomics"},{"key":"8245_CR58","doi-asserted-by":"crossref","first-page":"R711","DOI":"10.1152\/ajpregu.00310.2010","volume":"299","author":"MJ Heerwagen","year":"2010","unstructured":"Heerwagen MJ, Miller MR, Barbour LA, Friedman JE (2010) Maternal obesity and fetal metabolic programming: a fertile epigenetic soil. Am J Physiol Regul Integr Comp Physiol 299:R711\u2013R722","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"8245_CR59","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/nrrheum.2009.55","volume":"5","author":"E Karouzakis","year":"2009","unstructured":"Karouzakis E, Gay RE, Gay S, Neidhart M (2009) Epigenetic control in rheumatoid arthritis synovial fibroblasts. Nat Rev Rheumatol 5:266\u2013272","journal-title":"Nat Rev Rheumatol"},{"key":"8245_CR60","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jaut.2009.03.007","volume":"33","author":"A Hewagama","year":"2009","unstructured":"Hewagama A, Richardson B (2009) The genetics and epigenetics of autoimmune diseases. J Autoimmun 33:3\u201311","journal-title":"J Autoimmun"},{"key":"8245_CR61","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4161\/epi.3.3.6372","volume":"3","author":"B Youngblood","year":"2008","unstructured":"Youngblood B, Reich NO (2008) The early expressed HIV-1 genes regulate DNMT1 expression. Epigenetics 3:149\u2013156","journal-title":"Epigenetics"},{"key":"8245_CR62","doi-asserted-by":"crossref","first-page":"16899","DOI":"10.1073\/pnas.1009511107","volume":"107","author":"F Menconi","year":"2010","unstructured":"Menconi F, Osman R, Monti MC, Greenberg DA, Concepcion ES, Tomer Y (2010) Shared molecular amino acid signature in the HLA-DR peptide binding pocket predisposes to both autoimmune diabetes and thyroiditis. Proc Natl Acad Sci U S A 107:16899\u201316903","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8245_CR63","doi-asserted-by":"crossref","first-page":"34231","DOI":"10.1074\/jbc.M109.041574","volume":"284","author":"YH EM","year":"2009","unstructured":"EM YH, Menconi F et al (2009) Employing a recombinant HLA-DR3 expression system to dissect MHC II-thyroglobulin peptide dynamism: a genetic, biochemical, and reverse immunological perspective. J Biol Chem 284:34231\u201334243","journal-title":"J Biol Chem"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-010-8245-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-010-8245-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-010-8245-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,3]],"date-time":"2024-04-03T00:21:52Z","timestamp":1712103712000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-010-8245-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,14]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["8245"],"URL":"https:\/\/doi.org\/10.1007\/s12016-010-8245-8","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,14]]}}}